Yu G, Corn PG, Shen PF, Song JH, et al. Retinoic acid receptor activation reduces metastatic prostate cancer bone lesions by blocking the endothelial-to-osteoblast transition. Cancer Res 2022 Jul 8. pii: 706930. doi: 10.1158/0008-5472.CAN-22-0170.
PMID: 35802768